Rosmarinic acid reverses non‐small cell lung cancer cisplatin resistance by activating the MAPK signaling pathway

Cisplatin (DDP) is one of the first‐line chemotherapeutic agents for non‐small cell lung cancer (NSCLC). However, repeated use of cisplatin in clinical practice often induces chemoresistance. The aims of this study were to investigate whether rosmarinic acid (RA) could reverse multidrug resistance (...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Phytother Res
Main Authors: Liao, Xiao‐Zhong, Gao, Ying, Sun, Ling‐Ling, Liu, Jia‐Hui, Chen, Han‐Rui, Yu, Ling, Chen, Zhuang‐Zhong, Chen, Wen‐Hui, Lin, Li‐Zhu
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley & Sons, Ltd. 2020
Assuntos:
Research Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7217221/
https://ncbi.nlm.nih.gov/pubmed/31985119
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ptr.6584
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados